NUVL

NuvalentB

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

At close

2026-07-20

View Chart

Curated Events

Active

Recent Headlines

New

Curated events

Materiality

85.25

m&a

Source

External coverage

Decided

2026-06-11

Nuvalent Stock Soars on $10.6 Billion GSK Buyout

GSK agreed to acquire Nuvalent in a $10.6 billion deal, creating a clear positive takeover read-through for NUVL and a modest near-term dilution/integration overhang for GSK despite strategic oncology pipeline benefits.

View event details7 more curated

Sentiment decomposition

30-day score

Company-55%

Macro-30%

Pulse-15%

The 30-day sentiment score is a decayed blend of Company, Macro, and Pulse components.

Recent headlines

No supplemental ticker headlines stored yet

We are still collecting relevant articles for NUVL. Curated events highlight the most material developments impacting this ticker right now.

Check curated events Open full news archive

As of 2026-06-11 • Updated scheduledSource: News desk